| RS1755081510 |
SLC26A2
|
Health Risk |
Pathogenic |
Diastrophic dysplasia, Diastrophic dysplasia |
| RS1755082448 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1755088251 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS1755089179 |
SLC26A2
|
Health Risk |
Pathogenic |
Atelosteogenesis type II, Diastrophic dysplasia |
| RS1755089566 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfate transporter-related osteochondrodysplasia, Diastrophic dysplasia |
| RS1755093032 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS1755094376 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfate transporter-related osteochondrodysplasia, Atelosteogenesis type II |
| RS1755096552 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Diastrophic dysplasia, Achondrogenesis |
| RS1755100270 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia |
| RS1755106202 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Sulfate transporter-related osteochondrodysplasia, Sulfate transporter-related osteochondrodysplasia |
| RS1755110758 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia |
| RS1755124330 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Inborn genetic diseases |
| RS1755161249 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS1755164133 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1755166497 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS1755224830 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1755286581 |
HINT1
|
Health Risk |
Pathogenic |
— |
| RS1755319649 |
CTNNA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1755324870 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1755330256 |
GABRA1
|
Health Risk |
Pathogenic |
Idiopathic generalized epilepsy, Epilepsy |
| RS1755333582 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Epilepsy |
| RS1755334003 |
GABRA1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy |
| RS1755336735 |
CTNNA1
|
Health Risk |
Pathogenic |
— |
| RS1755338662 |
GABRA1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 19 |
| RS1755339912 |
GABRA1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 19 |
| RS1755340949 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Epilepsy |
| RS1755341108 |
GABRA1
|
Health Risk |
Pathogenic |
Idiopathic generalized epilepsy, Epilepsy |
| RS1755365079 |
HINT1
|
Health Risk |
Pathogenic |
— |
| RS1755403182 |
MYOT
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS1755409878 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Epilepsy |
| RS1755452892 |
MED12L
|
Health Risk |
Pathogenic |
— |
| RS1755509433 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1755607724 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1755639151 |
CAMK2A
|
Health Risk |
Likely pathogenic |
— |
| RS1755666734 |
LYRM7
|
Health Risk |
Pathogenic |
— |
| RS1755688091 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1755691727 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1755693558 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1755703455 |
PROP1
|
Health Risk |
Pathogenic |
— |
| RS1755861358 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Febrile seizures, familial |
| RS1755899012 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1755922883 |
CAMK2A
|
Health Risk |
Pathogenic |
— |
| RS1755969817 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1755980161 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1755987983 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1756023411 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1756051391 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1756058470 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1756068240 |
SLC6A3
|
Health Risk |
Likely pathogenic |
Classic dopamine transporter deficiency syndrome, Classic dopamine transporter deficiency syndrome |
| RS1756203781 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS1756212683 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS1756220614 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1756282703 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS1756316465 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1756328793 |
DOCK2
|
Health Risk |
Pathogenic |
DOCK2 deficiency, DOCK2 deficiency |
| RS1756331894 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1756333400 |
MED12L
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1756336297 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1756339861 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic or attenuated familial adenomatous polyposis, Familial adenomatous polyposis 1 |
| RS1756369186 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1756409749 |
SLC6A3
|
Health Risk |
Pathogenic |
Parkinsonism-dystonia, infantile |
| RS1756441567 |
GRXCR2
|
Health Risk |
Pathogenic |
— |
| RS1756441909 |
SPINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1756475997 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1756477033 |
APC
|
Health Risk |
Pathogenic |
Colorectal cancer, Familial adenomatous polyposis 1 |
| RS1756480727 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1756503149 |
GABRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS1756517678 |
NSD1
|
Health Risk |
Likely pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1756522180 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1756728108 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1756866850 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS1756936101 |
TRIO
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1757084798 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1757092904 |
CSF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia, Frontotemporal dementia |
| RS1757197459 |
CSF1R
|
Health Risk |
Likely pathogenic |
Brain abnormalities, neurodegeneration |
| RS1757202231 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS1757203198 |
CSF1R
|
Health Risk |
Pathogenic |
Leukoencephalopathy, diffuse hereditary |
| RS1757271243 |
TUBB2B
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 7, Complex cortical dysplasia with other brain malformations 7 |
| RS1757276859 |
TUBB2B
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 7, Complex cortical dysplasia with other brain malformations 7 |
| RS1757277674 |
TUBB2B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1757279879 |
TUBB2B
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS1757363484 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1757372234 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS1757380540 |
BLOC1S5
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 11, Hermansky-Pudlak syndrome 11 |
| RS1757381494 |
BLOC1S5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 11, Hermansky-Pudlak syndrome 11 |
| RS1757419927 |
CSF1R
|
Health Risk |
Pathogenic |
— |
| RS1757422149 |
CSF1R
|
Health Risk |
Pathogenic |
Leukoencephalopathy, diffuse hereditary |
| RS1757433662 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1757460270 |
NDUFA2
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 13 |
| RS1757478199 |
CSF1R
|
Health Risk |
Pathogenic |
Hereditary diffuse leukoencephalopathy with spheroids, Hereditary diffuse leukoencephalopathy with spheroids |
| RS1757528753 |
CSF1R
|
Health Risk |
Likely pathogenic |
Hereditary diffuse leukoencephalopathy with spheroids, Leukoencephalopathy |
| RS1757529135 |
CSF1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary diffuse leukoencephalopathy with spheroids, Leukoencephalopathy |
| RS1757571583 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1757572270 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1757573424 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1757581465 |
F13A1
|
Health Risk |
Pathogenic |
Factor XIII, A subunit |
| RS1757588488 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS1757597156 |
GHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS1757602433 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1757676761 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |